An intravenous insulin protocol designed for pregnancy reduces neonatal hypoglycaemia following betamethasone administration in women with gestational diabetes

ConclusionsAn IVI protocol designed for pregnancy effectively controlled maternal hyperglycaemia following betamethasone administration in GDM. This is the first intervention to show a reduction in betamethasone ‐associated neonatal hypoglycaemia, linked with optimum maternal glycaemic control.This article is protected by copyright. All rights reserved.

Source: Diabetic Medicine - November 15, 2018 Category: Endocrinology Authors: C. W. Rowe, E. Putt, O. Brentnall, A. Gebuehr, J. Allabyrne, A. Woods, K. Wynne Tags: Research Article Source Type: research